Table 3 Distribution of the 20 most requested medicines in lawsuits and concentration of lawyers and physicians, São Paulo, 2010–2014
From: Legal access to medications: a threat to Brazil’s public health system?
Item | Lawyer - percentile (%) | Prescriber - percentile (%) | ||||||
|---|---|---|---|---|---|---|---|---|
25% | 50% | 75% | 100% | 25% | 50% | 75% | 100% | |
Insulin glargine - vial/cartridge/disposable pen | 12.3 | 24.5 | 38.1 | 100 | 9.4 | 18.9 | 35.8 | 100 |
Insulin aspart - vial/cartridge/disposable pen | 12.0 | 24.1 | 30.1 | 100 | 10.0 | 19.9 | 36.8 | 100 |
Methylphenidate - capsule/extended-release tablet | 9.8 | 19.5 | 34.9 | 100 | 5.6 | 11.5 | 24.5 | 100 |
Ranibizumab - ampoule | 14.1 | 28.3 | 42.4 | 100 | 5.6 | 11.4 | 23.5 | 100 |
Insulin lispro - vial/cartridge/disposable pen | 12.5 | 24.9 | 38.6 | 100 | 11.6 | 23.3 | 42.0 | 100 |
Acetylsalicylic acid (100–325 mg) - tablet/coated tablet/slow-release tablet | 13.3 | 26,4 | 41.2 | 100 | 14.1 | 28.2 | 44.6 | 100 |
Clopidogrel - tablet | 15.7 | 31.5 | 47.2 | 100 | 15.5 | 14.7 | 46.6 | 100 |
Levothyroxine (38–200 mcg) - tablet | 14.6 | 29.1 | 49.2 | 100 | 14.7 | 29.2 | 49.2 | 100 |
Glucosamine + chondroitin - sachet/tablet | 16.7 | 33.5 | 50.2 | 100 | 23.3 | 45.2 | 73.9 | 100 |
Cinacalcet hydrochloride - coated tablet | 14.2 | 29.3 | 43.9 | 100 | 7.3 | 14.6 | 31.6 | 100 |
Boceprevir 200 mg - gelatinous capsule | 7.6 | 15.3 | 22.9 | 100 | 3.7 | 7.5 | 16.2 | 100 |
Simvastatin (5–80 mg)/tablet | 15.0 | 30.8 | 46.8 | 100 | 16.5 | 33.1 | 49.6 | 100 |
Insulin detemir - cartridge/disposable pen | 15.7 | 31.4 | 47.1 | 100 | 12.7 | 25.4 | 44.0 | 100 |
Omeprazole/tablet/capsule | 24.9 | 49.7 | 75.1 | 100 | 19.9 | 39.9 | 59.7 | 100 |
Insulin glulisine - vial/cartridge/disposable pen | 13.5 | 27.1 | 40.7 | 100 | 11.2 | 22.4 | 41.6 | 100 |
Sodium hyaluronate - injectable solution/vial | 15.7 | 28.7 | 47.5 | 100 | 16.0 | 39.4 | 81.2 | 100 |
Pregabalin - capsule | 14.7 | 29.5 | 44.5 | 100 | 14.6 | 29.0 | 46.1 | 100 |
Metformin + vildagliptin - capsule | 15.9 | 31.9 | 48.4 | 100 | 12.7 | 25.5 | 41.8 | 100 |
Rosuvastatin (5–40 mg) - tablet | 15.8 | 31.6 | 49.4 | 100 | 15.7 | 31.3 | 48.3 | 100 |
Zoledronic acid - injectable solution/vial | 14.0 | 29.5 | 42.1 | 100 | 9.7 | 19.3 | 31.5 | 100 |